# Study to Evaluate Efficacy and Safety of IW-6118 in Patients Undergoing Third Molar Extraction

> **NCT01107236** · PHASE2 · COMPLETED · sponsor: **Ironwood Pharmaceuticals, Inc.** · enrollment: 90 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** IW-6118
- **DRUG:** Matching Placebo
- **DRUG:** Naproxen Sodium

## Key facts

- **NCT ID:** NCT01107236
- **Lead sponsor:** Ironwood Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-06
- **Primary completion:** 2010-08
- **Final completion:** 2010-08
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2022-08-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01107236

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01107236, "Study to Evaluate Efficacy and Safety of IW-6118 in Patients Undergoing Third Molar Extraction". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01107236. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*